miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53

Lee, KJ; Singh, N; Bizuneh, M; Kim, NH; Kim, HS; Kim, Y; Lee, JJ; Kim, JH; Kim, J; Jeong, SY; Cho, HY; Park, ST

Cho, HY; Park, ST (通讯作者)，Hallym Univ, Inst New Frontier Res Team, Chunchon 24252, South Korea.;Park, ST (通讯作者)，Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Med Ctr,Dept Obstet & Gynecol, Seoul 07441, South Korea.;Cho, HY (通讯作者)，Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Med Ctr,Dept Obstet & Gynecol, Hwaseong 18450, Kyeonggido, South Korea.

JOURNAL OF PERSONALIZED MEDICINE, 2023; 13 (9):

Abstract

(1) Background: To examine miR-429-meditated DEAD (Asp-Glu-Ala-Asp) box polypeptide 53 (DDX53) function in endometrial cancer (EC). (2) Methods: DDX53......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索